The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity

被引:0
|
作者
Mengdie Luo
Ziyu Zhang
Yani Peng
Shuai Wang
Daoquan Peng
机构
[1] The Second Xiangya Hospital,Department of Cardiovascular Medicine
[2] Central South University,Department of Metabolism & Endocrinology
[3] The Second Xiangya Hospital,undefined
[4] Central South University,undefined
来源
Cardiovascular Diabetology | / 17卷
关键词
ANGPTL8; Cholesterol efflux capacity; Coronary artery disease; Diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 48 条
  • [21] HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
    Tejera-Segura, Beatriz
    Macia-Diaz, Maria
    David Machado, Jose
    de Vera-Gonzalez, Antonia
    Garcia-Dopico, Jose A.
    Olmos, Jose M.
    Hernandez, Jose L.
    Diaz-Gonzalez, Federico
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [22] Insulin Suppresses HDL-Mediated Cholesterol Efflux from Macrophages Through Inhibition of Neutral Cholesteryl Ester Hydrolase and ATP-Binding Cassette Transporter G1 Expressions
    Yamashita, Maki
    Tamasawa, Naoki
    Matsuki, Kota
    Tanabe, Jutaro
    Murakami, Hiroshi
    Matsui, Jun
    Suda, Toshihiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (11) : 1183 - 1189
  • [23] HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma
    Adorni, Maria Pia
    Biolo, Marta
    Zimetti, Francesca
    Palumbo, Marcella
    Ronda, Nicoletta
    Scarinzi, Paolo
    Simioni, Paolo
    Lupo, Maria Giovanna
    Ferri, Nicola
    Previato, Lorenzo
    Bernini, Franco
    Zambon, Alberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [24] Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
    Sanchez-Perez, Hiurma
    Quevedo-Abeledo, Juan Carlos
    De Armas-Rillo, Laura
    Rua-Figueroa, Inigo
    Tejera-Segura, Beatriz
    Armas-Gonzalez, Estefania
    Machado, Jose David
    Garcia-Dopico, Jose A.
    Jimenez-Sosa, Alejandro
    Rodriguez-Lozano, Carlos
    Diaz-Gonzalez, Federico
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    RHEUMATOLOGY, 2020, 59 (10) : 2847 - 2856
  • [25] Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study
    Costacou, Tina
    Miller, Rachel G.
    Bornfeldt, Karin E.
    Heinecke, Jay W.
    Orchard, Trevor J.
    Vaisar, Tomas
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (02) : e218 - e229
  • [26] Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients
    Miyamoto-Sasaki, Maki
    Yasuda, Tomoyuki
    Monguchi, Tomoko
    Nakajima, Hideto
    Mori, Kenta
    Toh, Ryuji
    Ishida, Tatsuro
    Hirata, Ken-ichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2013, 20 (09) : 708 - 716
  • [27] HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
    Denimal, Damien
    Monier, Serge
    Simoneau, Isabelle
    Duvillard, Laurence
    Verges, Bruno
    Bouillet, Benjamin
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [28] Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
    Munoz-Hernandez, Liliana
    Ortiz-Bautista, Raul J.
    Brito-Cordova, Griselda
    Lozano-Arvizu, Francisco
    Saucedo, Sharim
    Perez-Mendez, Oscar
    Zentella-Dehesa, Alejandro
    Dauteuille, Carolane
    Lhomme, Marie
    Lesnik, Philippe
    Chapman, M. John
    Kontush, Anatol
    Aguilar Salinas, Carlos A.
    ATHEROSCLEROSIS, 2018, 277 : 72 - 79
  • [29] Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users
    de Souza, Francis Ribeiro
    Dos Santos, Marcelo Rodrigues
    Porello, Rafael Armani
    Peixoto da Fonseca, Guilherme Wesley
    Carrari Sayegh, Ana Luiza
    Lima, Thais Pinheiro
    Ferreira, Fabiana Dias
    de Oliveira, Tiago Franco
    Yonamine, Mauricio
    Takayama, Liliam
    Rodrigues Pereira, Rosa Maria
    Negrao, Carlos Eduardo
    Passarelli, Marisa
    Rochitte, Carlos Eduardo
    de Nazare Nunes Alves, Maria Janieire
    ATHEROSCLEROSIS, 2019, 283 : 100 - 105
  • [30] Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity
    Kjellmo, Christian Abendstein
    Karlsson, Helen
    Nestvold, Torunn K.
    Ljunggren, Stefan
    Cederbrant, Karin
    Marcusson-Stahl, Maritha
    Mathisen, Monica
    Lappegard, Knut Tore
    Hovland, Anders
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (01) : 193 - 202